Kumar Neil's Form 4 filing
BridgeBio Pharma, Inc. (BBIO) · filed Aug 18, 2026
- Accession no.
- 0001470831-26-000836
- Filed
- Aug 18, 2026, 6:02 PM ET
- Trade date
- Aug 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kumar NeilCIK 0001742485 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2026 | Common Stock | MOption exerciseAcquired | +33,544 | –F1 | – | 276,871 | Direct | |
| Aug 16, 2026 | Common Stock | MOption exerciseAcquired | +19,599 | –F1 | – | 296,470 | Direct | |
| Aug 16, 2026 | Common Stock | MOption exerciseAcquired | +11,554 | –F1 | – | 308,024 | Direct | |
| Aug 16, 2026 | Common Stock | MOption exerciseAcquired | +6,520 | –F1 | – | 314,544 | Direct | |
| Aug 16, 2026 | Common Stock | FTax withholdingDisposed | −36,237 | $79.86 | −$2,893,886.82 | 278,307 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2026 | Common Stock | MOption exerciseDisposed | −33,544 | $0.00 | $0 | 67,088 | Direct | |
| Aug 16, 2026 | Common Stock | MOption exerciseDisposed | −19,599 | $0.00 | $0 | 117,596 | Direct | |
| Aug 16, 2026 | Common Stock | MOption exerciseDisposed | −11,554 | $0.00 | $0 | 115,538 | Direct | |
| Aug 16, 2026 | Common Stock | MOption exerciseDisposed | −6,520 | $0.00 | $0 | 91,274 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
Referenced by the price of 4 transactions in Table I.